Skip to content

Clinical trials

Phase 1/2 Lymphoma, Large-Cell, Anaplastic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Phase: Phase 1/2 Country / region: France Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Completed1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb1
Millennium Pharmaceuticals, Inc.1
Princess Maxima Center for Pediatric Oncology1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic4
Granuloma, Plasma Cell2
Hodgkin Disease2
Lymphoma2
Burkitt Lymphoma1
Glioblastoma1
Glioma1
Lymphoma, Extranodal NK-T-Cell1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Non-Hodgkin1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.